Borosil Scientific financials

Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹115cr+7.5% on Q2 FY26
Net profit
₹5.3cr+86.4% on Q2 FY26
EBITDA margin
9.3%+1.8 pts on Q2 FY26
EPS
₹0.60+87.5% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue115107+7.5%
EBITDA10.78.0+33.4%
EBITDA margin9.3%7.5%+1.8 pts
Profit before tax7.75.1+49.4%
Net profit5.32.8+86.4%
EPS₹0.60₹0.32+87.5%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹115 crNet profit₹5.3 crNet margin4.6%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
919——
134136119
0.20.20.2
8.18.114.1
793——
486467438
—+6.6%—
68.562.252.6
14.1%13.3%12.0%
48.843.034.1
45.634.626.7
9.4%7.4%6.1%
₹5.12₹3.89₹3.01
—+29.1%—
—43.3120
—−28.5−14.2
14.814.8106
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BOROSCI₹103.27

Borosil Scientific Limited

· Capital Goods & Defence
₹ CrorePeersSEJALLTDMcap ₹919 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——918.6
- Cash, Equiv & ST Investments118.7135.6134.0
+ Minority Interest0.20.20.2
+ Total Debt14.18.18.1
Enterprise Value——792.7
Revenue438.5467.3486.2
Growth %, YoY—+6.6—
EBITDA52.662.268.5
Margin %11.9913.3114.08
EBIT34.143.048.8
Net Income26.734.645.6
Margin %6.097.409.38
EPS, Adj (current shares)3.013.895.12
Growth %, YoY—+29.1—
Cash from Operations120.043.3—
Capital Expenditures-14.2-28.5—
Free Cash Flow105.914.814.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Borosil Scientific financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Borosil Scientific (NSE: BOROSCI) had a market capitalisation of ₹905 crore at the 30 October 2026 close (₹101.73 a share), a PE ratio of 19.9 on the last four quarters' profit and a price-to-book ratio of 2.00. In FY26 its consolidated net profit was ₹34.6 crore on revenue of ₹467 crore; in Q2 FY27 (July–September 2026) it was ₹5.3 crore, up 83.7% year on year. Its debt-to-equity ratio was 0.01 on 30 September 2026. Promoters held 68.27% of the shares on 30 September 2026.

Share price used
₹101.73 · 30 October 2026 close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

Borosil Scientific at a glance · consolidated

Market cap
₹905 Crat ₹101.73 · 30 Oct close
PE ratio (last 4 quarters)
19.926.1 on FY26 profit
Price to book (PB)
2.00book value ₹50.77 a share
ROE (FY26)
8.2%ROCE 9.8%
Debt to equity
0.01net cash ₹129 Cr
Promoter holding
68.27%unchanged vs 30 Jun 202630 September 2026
Net worth
₹452 Cr+11.7% vs 30 Sep 202530 September 2026
Free cash flow (FY26)
₹14.8 Cr−86.0% vs FY25
EPS (FY26)
₹3.89

Questions

What is the Borosil Scientific PE ratio today?

Borosil Scientific's PE ratio is 19.9 at the 30 October 2026 close (₹101.73 a share): a market capitalisation of ₹905 crore divided by consolidated net profit of ₹45.6 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹34.6 crore) it is 26.1.

What is the Borosil Scientific debt to equity ratio?

Borosil Scientific's debt-to-equity ratio was 0.01 on 30 September 2026: borrowings of ₹5.2 crore against total equity of ₹452 crore. A year earlier, on 30 September 2025, it was 0.02.

What is the Borosil Scientific net worth?

Borosil Scientific's net worth — shareholders' equity in its consolidated balance sheet — was ₹452 crore on 30 September 2026, up 11.7% from ₹404 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹905 crore at the 30 October 2026 close.

What is the Borosil Scientific PB ratio (price to book value)?

Borosil Scientific's price-to-book (PB) ratio is 2.00 at the 30 October 2026 close: a market capitalisation of ₹905 crore divided by shareholders' equity (book value) of ₹452 crore on 30 September 2026. That is a book value of ₹50.77 per share against a share price of ₹101.73.

What is the Borosil Scientific ROE and ROCE?

In FY26, Borosil Scientific's return on equity (ROE) was 8.2% and its return on capital employed (ROCE) was 9.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).

What is the Borosil Scientific book value per share?

Borosil Scientific's book value per share was ₹50.77 on 30 September 2026: shareholders' equity of ₹452 crore divided by the 8.9 crore shares in issue, up 11.7% from ₹45.47 a year earlier. The share price at the 30 October 2026 close was ₹101.73.

What is the Borosil Scientific market cap?

Borosil Scientific's market capitalisation was ₹905 crore at the 30 October 2026 close: 8.9 crore shares at ₹101.73 each.

Is Borosil Scientific debt free?

No. Borosil Scientific had borrowings of ₹5.2 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.01. Its cash and current investments were ₹135 crore, so it held net cash of ₹129 crore.

What is the Borosil Scientific EPS?

Borosil Scientific's basic earnings per share (EPS) were ₹3.89 in FY26, against ₹3.02 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹5.13.

What is the Borosil Scientific promoter holding?

Promoters held 68.27% of Borosil Scientific on 30 September 2026, unchanged from the previous quarter and up 0.46 percentage points from 67.81% a year earlier, according to the shareholding pattern filed with NSE.

What is the Borosil Scientific free cash flow?

In FY26, Borosil Scientific generated ₹43.3 crore of cash from operations and spent ₹28.5 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹14.8 crore. In FY25 it was ₹106 crore.

What is the Borosil Scientific revenue and profit in FY26?

In FY26 (April 2025–March 2026), Borosil Scientific's consolidated net profit was ₹34.6 crore, up 29.1% from ₹26.8 crore in FY25, on revenue from operations of ₹467 crore (up 6.6%).

What is the Borosil Scientific shareholding pattern?

On 30 September 2026, Borosil Scientific's shares were held by promoters 68.27%, foreign portfolio investors (FII/FPI) 0.14%, domestic institutions (DII) 0.28% (including mutual funds at 0.01%) and retail and other non-institutional investors 31.31%. Over the year, FII holding was up 0.07 percentage points from 0.07% and DII holding was up 0.18 percentage points from 0.10%.

What are the Borosil Scientific latest quarterly results?

Borosil Scientific's latest results are for Q2 FY27 (July–September 2026), filed on 28 October 2026: consolidated net profit ₹5.3 crore, up 83.7% from ₹2.9 crore in Q2 FY26; revenue from operations ₹115 crore, up 7.5% year on year.

Borosil Scientific vs Sejal Glass: how do they compare?

In FY26, Borosil Scientific earned net profit of ₹34.6 crore on revenue of ₹467 crore, against ₹28.7 crore on ₹397 crore for Sejal Glass. Borosil Scientific's operating margin was 9.2% (Sejal Glass 11.6%) and its return on equity 8.2% (Sejal Glass 30.4%). At the 30 October 2026 close, Borosil Scientific's market capitalisation was ₹905 crore against ₹882 crore for Sejal Glass, and its PE ratio on FY26 profit 26.1 against 30.7.

When are the Borosil Scientific next results?

Borosil Scientific has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

How does Borosil Scientific compare with its peers?

On FY26 consolidated figures, against Sejal Glass: Borosil Scientific's operating margin of 9.2% is the lower of the two (Sejal Glass 11.6%; peer average 11.6%); its return on equity of 8.2% is the lower of the two (Sejal Glass 30.4%; peer average 30.4%).

How does the Borosil Scientific PE ratio compare with its peers?

At the 30 October 2026 closing prices, on FY26 net profit, Borosil Scientific's PE ratio is 26.1, the lower of the two: Sejal Glass 30.7, a peer average of 30.7. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Where do these Borosil Scientific figures come from?

From Borosil Scientific's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.